Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

New research shows that corticosteroid injections for knee OA treatment do not hasten a patient's progression to a total knee replacement when compared with hyaluronic acid injections. Details of this ...

Please provide your email address to receive an email when new articles are posted on . Use of corticosteroid injections did not exacerbate radiographic progression of knee osteoarthritis or ...

Genicular Artery Embolization (GAE) represents a new paradigm in treating knee osteoarthritis that had hitherto been handled ...

Please provide your email address to receive an email when new articles are posted on . Knee osteoarthritis accounts for about 80% of the burden of OA worldwide, and published studies show it ...

Approximately 14 million people in the US have knee osteoarthritis (OA). By the age of 60, about 10% of men and 13% of women are affected by symptomatic knee OA. Knee osteoarthritis is a chronic joint ...

Ladan Nikravan Hayes, for Flexion Therapeutics, Inc. Joe West, 68, isn’t a stranger to knee pain. In high school, sports were his greatest passion — football, wrestling, golf, it didn’t matter the ...

Biomechanical footwear calibrated for individual use demonstrated a significant improvement in the pain scores of individuals with knee osteoarthritis after 24 weeks in a recent trial. Although the ...

Knee lesions apparent on magnetic resonance imaging (MRI) and worsening over the subsequent 12 to 48 months predicted subsequent development of symptomatic, radiographically apparent knee ...

Yoga and strengthening exercises both reduced knee pain in patients with knee osteoarthritis (OA) over 12 weeks, with no significant difference between them. Over 24 weeks, yoga led to modest ...

A new study has found the non-invasive application of in-ear electrical stimulation to the vagus nerve to be safe and effective in reducing osteoarthritis-related knee pain. It opens the door to ...

A new study presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that after three months of treatment with oral methotrexate, adults with primary knee ...